The national and subnational burden of Non-Hodgkin Lymphomas (NHL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023.

ABSTRACT:

Background

Non-Hodgkin Lymphomas (NHL) are a large group of 70 different oncohematological malignancies. This study investigated the global burden of NHL and its temporal trends from 1990 to 2023, at the Italian national and subnational level (21 regions/provinces).

Methods

We used the Global Burden of Disease Study 2023 estimates to describe the NHL age-standardized incidence (ASIR), mortality (ASMR), years lived with disability (ASYLD), years of life lost (ASYLL), disability-adjusted life years (ASDR) rates, the related 1990-2023 crude all-ages and age-standardized annual rate of changes (ARC), as well as the age-standardized mortality-to-incidence ratio (MIR). Finally, the national estimates for NHL were compared to those for the GBD Global and High-middle Socio-Demograph

SUBMITTER: GBD 2023 Italian Non-Hodgkin Lymphoma Collaborators 

PROVIDER: S-EPMC12572794 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature